The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Daunorubicin Hydrochloride Market Research Report 2025
Synopsis
Daunorubicin hydrochloride (CAS 23541-50-6), C27H30ClNO10, the formula weight is 563.98, and its form is red to deep red soild.
The global Daunorubicin Hydrochloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Daunorubicin hydrochloride is used to treat acute myeloid leukemia, acute lymphocytic leukemia and other tumors.
This report aims to provide a comprehensive presentation of the global market for Daunorubicin Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daunorubicin Hydrochloride.
Report Scope
The Daunorubicin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Daunorubicin Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daunorubicin Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisun Pharma
Main Luck Pharma
Pfizer
Cipla
TEVA
Medior Healthcare
United Biotech
West-Ward
Segment by Type
5mg/ml
2mg/ml
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daunorubicin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daunorubicin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Daunorubicin hydrochloride (CAS 23541-50-6), C27H30ClNO10, the formula weight is 563.98, and its form is red to deep red soild.
The global Daunorubicin Hydrochloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Daunorubicin hydrochloride is used to treat acute myeloid leukemia, acute lymphocytic leukemia and other tumors.
This report aims to provide a comprehensive presentation of the global market for Daunorubicin Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daunorubicin Hydrochloride.
Report Scope
The Daunorubicin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Daunorubicin Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daunorubicin Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisun Pharma
Main Luck Pharma
Pfizer
Cipla
TEVA
Medior Healthcare
United Biotech
West-Ward
Segment by Type
5mg/ml
2mg/ml
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daunorubicin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daunorubicin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Daunorubicin Hydrochloride Market Overview
1.1 Product Overview and Scope of Daunorubicin Hydrochloride
1.2 Daunorubicin Hydrochloride Segment by Type
1.2.1 Global Daunorubicin Hydrochloride Market Value Comparison by Type (2024-2030)
1.2.2 5mg/ml
1.2.3 2mg/ml
1.3 Daunorubicin Hydrochloride Segment by Application
1.3.1 Global Daunorubicin Hydrochloride Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Daunorubicin Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Daunorubicin Hydrochloride Revenue 2019-2030
1.4.2 Global Daunorubicin Hydrochloride Sales 2019-2030
1.4.3 Global Daunorubicin Hydrochloride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Daunorubicin Hydrochloride Market Competition by Manufacturers
2.1 Global Daunorubicin Hydrochloride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Daunorubicin Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Daunorubicin Hydrochloride Average Price by Manufacturers (2019-2024)
2.4 Global Daunorubicin Hydrochloride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daunorubicin Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daunorubicin Hydrochloride, Product Type & Application
2.7 Daunorubicin Hydrochloride Market Competitive Situation and Trends
2.7.1 Daunorubicin Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Daunorubicin Hydrochloride Players Market Share by Revenue
2.7.3 Global Daunorubicin Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Daunorubicin Hydrochloride Retrospective Market Scenario by Region
3.1 Global Daunorubicin Hydrochloride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Daunorubicin Hydrochloride Global Daunorubicin Hydrochloride Sales by Region: 2019-2030
3.2.1 Global Daunorubicin Hydrochloride Sales by Region: 2019-2024
3.2.2 Global Daunorubicin Hydrochloride Sales by Region: 2025-2030
3.3 Global Daunorubicin Hydrochloride Global Daunorubicin Hydrochloride Revenue by Region: 2019-2030
3.3.1 Global Daunorubicin Hydrochloride Revenue by Region: 2019-2024
3.3.2 Global Daunorubicin Hydrochloride Revenue by Region: 2025-2030
3.4 North America Daunorubicin Hydrochloride Market Facts & Figures by Country
3.4.1 North America Daunorubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Daunorubicin Hydrochloride Sales by Country (2019-2030)
3.4.3 North America Daunorubicin Hydrochloride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Daunorubicin Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Daunorubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Daunorubicin Hydrochloride Sales by Country (2019-2030)
3.5.3 Europe Daunorubicin Hydrochloride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daunorubicin Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Daunorubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Daunorubicin Hydrochloride Sales by Country (2019-2030)
3.6.3 Asia Pacific Daunorubicin Hydrochloride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Daunorubicin Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Daunorubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Daunorubicin Hydrochloride Sales by Country (2019-2030)
3.7.3 Latin America Daunorubicin Hydrochloride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Daunorubicin Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Daunorubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Daunorubicin Hydrochloride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Daunorubicin Hydrochloride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Daunorubicin Hydrochloride Sales by Type (2019-2030)
4.1.1 Global Daunorubicin Hydrochloride Sales by Type (2019-2024)
4.1.2 Global Daunorubicin Hydrochloride Sales by Type (2025-2030)
4.1.3 Global Daunorubicin Hydrochloride Sales Market Share by Type (2019-2030)
4.2 Global Daunorubicin Hydrochloride Revenue by Type (2019-2030)
4.2.1 Global Daunorubicin Hydrochloride Revenue by Type (2019-2024)
4.2.2 Global Daunorubicin Hydrochloride Revenue by Type (2025-2030)
4.2.3 Global Daunorubicin Hydrochloride Revenue Market Share by Type (2019-2030)
4.3 Global Daunorubicin Hydrochloride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Daunorubicin Hydrochloride Sales by Application (2019-2030)
5.1.1 Global Daunorubicin Hydrochloride Sales by Application (2019-2024)
5.1.2 Global Daunorubicin Hydrochloride Sales by Application (2025-2030)
5.1.3 Global Daunorubicin Hydrochloride Sales Market Share by Application (2019-2030)
5.2 Global Daunorubicin Hydrochloride Revenue by Application (2019-2030)
5.2.1 Global Daunorubicin Hydrochloride Revenue by Application (2019-2024)
5.2.2 Global Daunorubicin Hydrochloride Revenue by Application (2025-2030)
5.2.3 Global Daunorubicin Hydrochloride Revenue Market Share by Application (2019-2030)
5.3 Global Daunorubicin Hydrochloride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hisun Pharma
6.1.1 Hisun Pharma Corporation Information
6.1.2 Hisun Pharma Description and Business Overview
6.1.3 Hisun Pharma Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisun Pharma Daunorubicin Hydrochloride Product Portfolio
6.1.5 Hisun Pharma Recent Developments/Updates
6.2 Main Luck Pharma
6.2.1 Main Luck Pharma Corporation Information
6.2.2 Main Luck Pharma Description and Business Overview
6.2.3 Main Luck Pharma Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Main Luck Pharma Daunorubicin Hydrochloride Product Portfolio
6.2.5 Main Luck Pharma Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Daunorubicin Hydrochloride Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Daunorubicin Hydrochloride Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TEVA Daunorubicin Hydrochloride Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Medior Healthcare
6.6.1 Medior Healthcare Corporation Information
6.6.2 Medior Healthcare Description and Business Overview
6.6.3 Medior Healthcare Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Medior Healthcare Daunorubicin Hydrochloride Product Portfolio
6.6.5 Medior Healthcare Recent Developments/Updates
6.7 United Biotech
6.6.1 United Biotech Corporation Information
6.6.2 United Biotech Description and Business Overview
6.6.3 United Biotech Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 United Biotech Daunorubicin Hydrochloride Product Portfolio
6.7.5 United Biotech Recent Developments/Updates
6.8 West-Ward
6.8.1 West-Ward Corporation Information
6.8.2 West-Ward Description and Business Overview
6.8.3 West-Ward Daunorubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.8.4 West-Ward Daunorubicin Hydrochloride Product Portfolio
6.8.5 West-Ward Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daunorubicin Hydrochloride Industry Chain Analysis
7.2 Daunorubicin Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daunorubicin Hydrochloride Production Mode & Process
7.4 Daunorubicin Hydrochloride Sales and Marketing
7.4.1 Daunorubicin Hydrochloride Sales Channels
7.4.2 Daunorubicin Hydrochloride Distributors
7.5 Daunorubicin Hydrochloride Customers
8 Daunorubicin Hydrochloride Market Dynamics
8.1 Daunorubicin Hydrochloride Industry Trends
8.2 Daunorubicin Hydrochloride Market Drivers
8.3 Daunorubicin Hydrochloride Market Challenges
8.4 Daunorubicin Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
